Filing Details
- Accession Number:
- 0001114220-18-000060
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-31 16:20:56
- Reporting Period:
- 2018-05-29
- Accepted Time:
- 2018-05-31 16:20:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1114220 | Keryx Biopharmaceuticals Inc | KERX | Pharmaceutical Preparations (2834) | 134087132 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1398422 | J Kevin Cameron | C/O Keryx Biopharmaceuticals, Inc. One Marina Park Drive, 12Th Floor Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-05-29 | 1,667 | $5.22 | 168,333 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale of a total of 1,667 shares of common stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017.
- Includes 16,666 shares of restricted stock.
Billionaire Hedge Funds
